Novartis Shs Sponsored American Deposit Receipt Repr 1 Sh $89.73

down -0.27


28/8/2014 04:03 PM  |  : NVS  
Industries :
Get Trend Analysis Icon Get NVS Trend Analysis - it has underperformed the S&P 500 by 0%

Partner Headlines

  1. Novartis: Ten Years of Solid ROE

    GuruFocus
  2. Biogen, Gilead Crush Earnings Estimates On Hot Drugs

    IBD
  3. Biogen Trounces Q2 Estimates As Tecfidera Outperforms

    IBD
  4. 5 New Medical Technologies For Diabetics

    Benzinga
  5. Novartis Joins Google To Develop Contacts For Diabetics

    Benzinga
  6. #PreMarket Primer: Friday, July 18: Tension Between Russia And The West ...

    Benzinga
  7. Markets Sell-Off After Malaysian Airline Crash In Ukraine

    Benzinga
  8. Earnings Scheduled For July 17, 2014

    Benzinga
  9. Google's X division

    IBD
  10. Benzinga Weekly Preview: Earnings Season Kicks Into High Gear

    Benzinga
  11. NOVARTIS

    IBD
  12. Novartis Announces Beginning of Shipment of Seasonal Influenza Vaccines ...

    Benzinga
  13. US Stock Futures Edge Higher Ahead Of Consumer Price Index

    Benzinga
  14. IPO Stock Watch: Receptos Soars On MS Drug Results

    IBD
  15. Joseph Papa, A Generic CEO With Brand-Name Action

    IBD
  16. ASCO Meeting Day 1: Preserving Fertility And Reducing Side Effects

    Benzinga
  17. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus
  18. Top Held European Stocks Highlighted by Health Care and Oil and Gas Stocks

    GuruFocus
  19. Two New WisdomTree International ETFs (IHDG, EUDG, BHP, NVS)

    Benzinga
  20. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  21. Can Pfizer Make Up Its Loss?

    GuruFocus
  22. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  23. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  24. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  25. China Rule Change Further Opens Yuan To World Markets

    IBD
  26. These Three Pharmaceutical Companies Shake The Market With Their Deal

    GuruFocus
  27. Drugmakers' Q1 was anemic

    IBD
  28. RBC Optimistic on Regeneron Following Lower Sales by Novartis' Lucentis

    Benzinga
  29. UPDATE: Novartis Posts Rise In Q1 Profit

    Benzinga
  30. Earnings Scheduled For April 24, 2014

    Benzinga
  31. Big Pharmas Swap Specialties

    IBD
  32. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  33. Benzinga's M&A Chatter for Tuesday April 22, 2014

    Benzinga
  34. Valeant's Bid For Allergan Boosts Ethical Drug Stocks

    IBD
  35. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  36. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  37. S&P 500, Nasdaq Rise For Sixth Day As Volume Picks Up

    IBD
  38. Pharma Deal Frenzy: A Bid to Boost Profits, Cut Risk

    FoxBusiness
  39. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  40. Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

    Benzinga
  41. Novartis, Glaxo Swap Units; Lilly Buying Animal Biz

    IBD
  42. Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb

    IBD
  43. Novartis Announces Multi-Billion-Dollar Revamp

    FoxBusiness
  44. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  45. Stock Futures Steady Amid Raft of Health M&A

    FoxBusiness
  46. Wall Street Ticks Up as Traders Parse News Deluge

    FoxBusiness
  47. PetMed Express Inc. Is Trying Harder to Push Sales

    GuruFocus
  48. Mallinckrodt, Questcor Merger Gets Mixed Reception

    IBD
  49. Trial Results Lift Drug Sector

    IBD
  50. Stock Futures Look Favorable; Legg Mason, Novartis, Climb

    IBD
Trading Center